Yüklüyor......
A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer
Capecitabine plus oxaliplatin every 3 weeks (XELOX regimen) has proven efficacy in patients with colorectal carcinoma. We investigated this combination in patients with previously untreated advanced gastric carcinoma. The study population comprised patients with histologically confirmed nonresectabl...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2006
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361232/ https://ncbi.nlm.nih.gov/pubmed/16552439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603046 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|